Professor Nicholas Hart

His current roles include:

• Professor of respiratory and citical care medicine, Faculty of Life Sciences and Medicine, School of Basic and Medical BioSciences, King’s College London
• Director of research and development delivery, Guy’s and St Thomas’ NHS Foundation Trust
• Joint editor-in-chief, Thorax

Nicholas was appointed in April 2012 as the director of the Lane Fox Respiratory service, which is an internationally recognised weaning, rehabilitation and home mechanical ventilation service. Since taking over as head of service, Nicholas has increased the activity by the introduction of seven-day working, opened the Lane Fox-REMEO Centre, re-structured the outpatient clinics, outpatient service and home ventilation service and increased the acuity of the inpatient service with installation of a comprehensive electronic patient record and central monitoring system. This has required an enhancement of the specialist workforce including consultants, junior doctors, nurses, allied health care professionals, technicians and administrative staff to support the service across paediatrics and adults.

He was appointed as director of research delivery for Guy’ and Thomas’ Foundation Trust in 2016. He is also a member of the Guy’s and St Thomas’ Research Board of Directors, a group responsible for the research financial activity of the Trust. Nicholas manages the 18 research and development leads and 12 research managers to ensure the research strategy is delivered with the goal of promoting screening, recruitment and retention of patients to NIHR portfolio studies.

Nicholas has developed a technology that has an intellectual property patent in the Europe (US pending) and this has resulted with close collaborative industry links with Philips. He has a master research agreement with Philips to develop and commercialise the Myotrace technology, which involved supervising a signal processing engineer working in the Lane Fox Clinical Respiratory Physiology Research Centre. Nicholas was appointed to the Philips Global Executive Pulmonary Advisory Board in 2014 with a primary role to identify and develop new technologies for respiratory health.

• Enhance the long-term outcome of patients with chronic respiratory disease and post critical illness
• Readmission prevention in acute COPD
• Prevention of skeletal muscle wasting during acute illness
• Clinical trials to improve long-term outcome in sleep disordered breathing and chronic respiratory failure

Since 2007, Nicholas’ research has received a total grant income of over £7 million with over £3.5 million in grants as lead applicant or primary supervisor.

Since 2009, he has successfully supervised five King’s College London PhD students (primary supervisor), one University College London PhD student (secondary supervisor) and one Oxford University Doctor of Medicine (MD) student (secondary supervisor).

• Local Clinical Excellence Awards, 2016
• Best Acute Hospital Development Lane Fox REMEO Centre at the Building Better Healthcare Awards, 2015
• Highly Commended (personal commendation) for National Well-Child Award, 2014